These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 9266200)
21. Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen activator. Come PC; Kim D; Parker JA; Goldhaber SZ; Braunwald E; Markis JE J Am Coll Cardiol; 1987 Nov; 10(5):971-8. PubMed ID: 2959713 [TBL] [Abstract][Full Text] [Related]
22. Thrombolytic effects of tissue-type and urokinase-type plasminogen activators in rabbits with experimental pulmonary thromboembolization. Rahman F Fukuoka Igaku Zasshi; 1990 Sep; 81(9):303-12. PubMed ID: 2125971 [TBL] [Abstract][Full Text] [Related]
26. [Major prolongation of the QT interval observed in the course of massive pulmonary embolism]. de Meester A; Deltenre P; Chaudron JM Acta Clin Belg; 1995; 50(5):301-4. PubMed ID: 8533532 [TBL] [Abstract][Full Text] [Related]
27. Nephrotic syndrome complicated by life-threatening pulmonary embolism in an adult patient. Chen SC; Liu WC; Lee CH; Chang JM; Chen HC Kaohsiung J Med Sci; 2010 Feb; 26(2):89-95. PubMed ID: 20123597 [TBL] [Abstract][Full Text] [Related]
28. Saddle pulmonary embolism in a pediatric patient with nephrotic syndrome and recent COVID-19 pneumonia: A case report. Cristoforo T; McKinley G; Ambrosio P Am J Emerg Med; 2021 Oct; 48():376.e1-376.e2. PubMed ID: 33958247 [TBL] [Abstract][Full Text] [Related]
29. Effectiveness of low-dose prolonged infusion of tissue plasminogen activator in a nonagenarian patient with acute pulmonary embolism and main pulmonary artery thrombus. Yildiz M; Karakoyun S; Acar RD; Ozkan M Blood Coagul Fibrinolysis; 2013 Jan; 24(1):95-6. PubMed ID: 23037320 [TBL] [Abstract][Full Text] [Related]
30. Successful thrombolytic therapy of pulmonary embolism associated with urosepsis in an infant. Pugh KJ; Jureidini SB; Ream R; Syamasundar RP; Dossier J Pediatr Cardiol; 2002; 23(1):77-9. PubMed ID: 11922515 [TBL] [Abstract][Full Text] [Related]
31. [Pulmonary embolism as a complication of nephrotic syndrome--case report and therapeutic management]. Janowski R; Majdan M; Mika D; Mierzicki P; Drop A; Ksiazek A Wiad Lek; 1997; 50(4-6):123-7. PubMed ID: 9381715 [TBL] [Abstract][Full Text] [Related]
32. Clinical presentation and results of thrombolytic therapy in older patients with massive pulmonary embolism: a comparison with non-elderly patients. Gisselbrecht M; Diehl JL; Meyer G; Collignon MA; Sors H J Am Geriatr Soc; 1996 Feb; 44(2):189-93. PubMed ID: 8576511 [TBL] [Abstract][Full Text] [Related]
33. Successful treatment of massive pulmonary embolism with low-dose tissue plasminogen activator after meniscus surgery. Zencirkiran Agus H; Uygur B; Guler A; Demirci G; Kalkan AK; Yildiz M Blood Coagul Fibrinolysis; 2018 Sep; 29(6):559-561. PubMed ID: 29985194 [TBL] [Abstract][Full Text] [Related]
34. Thrombolytic treatment with recombinant tissue-type plasminogen activator in a patient with massive pulmonary embolism. Bounameaux H; Vermylen J; Collen D Ann Intern Med; 1985 Jul; 103(1):64-5. PubMed ID: 4039905 [No Abstract] [Full Text] [Related]
35. Pulmonary embolism and renal vein thrombosis in patients with nephrotic syndrome: prospective evaluation of prevalence and risk factors with CT. Zhang LJ; Zhang Z; Li SJ; Meinel FG; Nance JW; Zhou CS; Zhao YE; Schoepf UJ; Lu GM Radiology; 2014 Dec; 273(3):897-906. PubMed ID: 25072187 [TBL] [Abstract][Full Text] [Related]